Hasegawa Medical Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials

Phase

• Phase 34 trials

Status

• Completed4 trials

Lead sponsor

• Eli Lilly and Company4 trials

Closed trials

• Completed

  A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

  NCT06109311· Phase 3· Eli Lilly and Company· Source

• Completed

  A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

  NCT06010004· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

  NCT05971940· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

  NCT05362058· Phase 3· Eli Lilly and Company· Source